Medicus Pharma
MDCX
21 hedge funds and large institutions have $6.03M invested in Medicus Pharma in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 6 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
23% more capital invested
Capital invested by funds: $4.91M → $6.03M (+$1.12M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
5% more funds holding
Funds holding: 20 → 21 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3.88M |
| 2 |
Jane Street
New York
|
+$129K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$86K |
| 4 |
HF
HRT Financial
New York
|
+$59K |
| 5 |
WSFS
Wilmington Savings Fund Society
Wilmington,
Delaware
|
+$54.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
-$532K |
| 2 |
LPL Financial
San Diego,
California
|
-$43.4K |
| 3 |
BWM
Base Wealth Management
Lakewood Ranch,
Florida
|
-$26.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$11.8K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EWA
26
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$695 | -300 | Closed |
|
27
Citigroup
New York
| – | -$514 | -222 | Closed |
|
MDCX Hedge Fund Activity: Q4 2025 in Review
21 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q4 2025, worth a combined $6.03M — up 23% from $4.91M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MDCX positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $3.88M. The largest seller was Yorkville Advisors Global, exiting entirely with an estimated $532K sold.
- 21 institutional investors held Medicus Pharma (MDCX) as of Q4 2025, up from 20 in Q3 2025.
- Funds reported $6.03M of Medicus Pharma stock for Q4 2025, up 23% quarter-over-quarter.
- 7 funds opened new Medicus Pharma positions in Q4 2025 and 6 closed out, a net change of +1 holder.
- The largest Medicus Pharma buyer in Q4 2025 was Armistice Capital, an estimated $3.88M added.
- The largest Medicus Pharma seller in Q4 2025 was Yorkville Advisors Global, an estimated $532K sold.
Based on aggregated 13F filings for Q4 2025.